查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2105682

RNA分析全球市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global RNA Analysis Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球RNA分析市場預計將從2025年的91億美元成長至2034年的284億美元，2026年至2034年的複合年成長率（CAGR）為13.48%。隨著分子生物學研究和精準醫療不斷推動現代醫學和生命科學的變革，該市場正經歷顯著成長。 RNA分析技術廣泛應用於闡明基因表現、理解疾病機制、發現生物標記和藥物研發。基因組研究投入的增加、慢性病盛行率的上升以及對個人化醫療日益成長的需求，都在推動先進RNA分析解決方案的應用。生物技術和製藥領域不斷擴大的研究活動也進一步促進了全球醫療保健系統市場的發展。

次世代定序、聚合酵素鏈鎖反應(PCR)、轉錄組學和生物資訊學的進步正在提高 RNA 分析的速度、靈敏度和準確性。研究機構和製藥公司正擴大利用這些技術來加速藥物發現和臨床研究。政府對基因組學研究投入的增加，以及基因組學在癌症診斷和感染疾病研究領域應用的不斷拓展，為市場參與企業創造了巨大的商機。自動化和基於雲端的數據分析平台也有助於提高研究效率。

鑑於全球精準醫療和基因研究的持續進步，前景極為光明。人工智慧、機器學習和整合基因組分析將提升對複雜生物數據的解讀能力，並加速科學發現。伴隨診斷、個人化醫療和先進分子檢測日益成長的需求將推動市場長期擴張。隨著定序技術和實驗室自動化的不斷創新，RNA分析將成為未來生物醫學研究的基石。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球RNA分析市場：依產品類型分類

  • 市場分析、洞察與預測
  • 試劑/耗材
  • 裝置
  • 其他產品類型

第5章 全球RNA分析市場：依技術分類

  • 市場分析、洞察與預測
  • 微陣列
  • 定序
  • 聚合酵素鏈鎖反應（PCR）
  • 其他

第6章 全球RNA分析市場：依應用分類

  • 市場分析、洞察與預測
  • 臨床診斷
  • 藥物發現
  • 毒性基因組學
  • 其他用途

第7章 全球RNA分析市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 製藥和生物技術公司
  • 醫院和診斷中心
  • 其他

第8章 全球RNA分析市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche
    • Illumina
    • QIAGEN
    • Eurofins Scientific
    • Merck KGaA
    • Bio-Rad Laboratories
    • Agilent Technologies
    • Promega Corporation
    • GenXPro GmbH
    • BioMerieux SA
    • LC Sciences
    • Danaher Corporation
    • Revvity Inc
    • Pacific Biosciences（PacBio）
    • Oxford Nanopore Technologies
    • Takara Bio Inc
    • New England Biolabs
    • Standard BioTools
    • Azenta Life Sciences
簡介目錄
Product Code: VMR112119280

The global RNA analysis market size is expected to reach USD 28.40 Billion in 2034 from USD 9.10 Billion in 2025, growing at a CAGR of 13.48 during 2026-2034.This market is experiencing significant growth as molecular biology research and precision medicine continue transforming modern healthcare and life sciences. RNA analysis technologies are widely used to study gene expression, disease mechanisms, biomarker discovery, and drug development. Rising investments in genomics research, increasing prevalence of chronic diseases, and growing demand for personalized medicine are driving widespread adoption of advanced RNA analysis solutions. Expanding biotechnology and pharmaceutical research activities are further supporting market development across global healthcare systems.

Technological advancements in next-generation sequencing, polymerase chain reaction, transcriptomics, and bioinformatics are improving the speed, sensitivity, and accuracy of RNA analysis. Research organizations and pharmaceutical companies are increasingly utilizing these technologies to accelerate drug discovery and clinical research. Growing government funding for genomic research, coupled with expanding applications in cancer diagnostics and infectious disease studies, is creating substantial opportunities for market participants. Automation and cloud-based data analysis platforms are also enhancing research efficiency.

The future outlook remains highly promising as precision medicine and genetic research continue advancing worldwide. Artificial intelligence, machine learning, and integrated genomic analytics will improve interpretation of complex biological data and accelerate scientific discoveries. Increasing demand for companion diagnostics, personalized therapies, and advanced molecular testing will strengthen long-term market expansion. Continuous innovation in sequencing technologies and laboratory automation will position RNA analysis as a cornerstone of future biomedical research.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

  • Reagents/Consumables
  • Instruments
  • Other Product Types

By Technology

  • Microarrays
  • Sequencing
  • Polymerase Chain Reaction (PCR)
  • Others

By Application

  • Clinical Diagnostics
  • Drug Discovery
  • Toxicogenomics
  • Other Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals and Diagnostic Centers
  • Others

COMPANIES PROFILED

  • Thermo Fisher Scientific, F. Hoffmann-La Roche, Illumina, QIAGEN, Eurofins Scientific, Merck KGaA, Bio-Rad Laboratories, Agilent Technologies, Promega Corporation, GenXPro GmbH, bioMerieux SA, LC Sciences, Danaher Corporation, Revvity Inc., Pacific Biosciences (PacBio), Oxford Nanopore Technologies, Takara Bio Inc., New England Biolabs, Standard BioTools, Azenta Life Sciences

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL RNA ANALYSIS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Reagents/Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Other Product Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RNA ANALYSIS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Polymerase Chain Reaction (PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RNA ANALYSIS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Toxicogenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RNA ANALYSIS MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Hospitals and Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL RNA ANALYSIS MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product Type
    • 8.2.2 By Technology
    • 8.2.3 By Application
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product Type
    • 8.3.2 By Technology
    • 8.3.3 By Application
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product Type
    • 8.4.2 By Technology
    • 8.4.3 By Application
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product Type
    • 8.5.2 By Technology
    • 8.5.3 By Application
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product Type
    • 8.6.2 By Technology
    • 8.6.3 By Application
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL RNA ANALYSIS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Thermo Fisher Scientific
    • 10.2.2 F. Hoffmann-La Roche
    • 10.2.3 Illumina
    • 10.2.4 QIAGEN
    • 10.2.5 Eurofins Scientific
    • 10.2.6 Merck KGaA
    • 10.2.7 Bio-Rad Laboratories
    • 10.2.8 Agilent Technologies
    • 10.2.9 Promega Corporation
    • 10.2.10 GenXPro GmbH
    • 10.2.11 BioMerieux SA
    • 10.2.12 LC Sciences
    • 10.2.13 Danaher Corporation
    • 10.2.14 Revvity Inc
    • 10.2.15 Pacific Biosciences (PacBio)
    • 10.2.16 Oxford Nanopore Technologies
    • 10.2.17 Takara Bio Inc
    • 10.2.18 New England Biolabs
    • 10.2.19 Standard BioTools
    • 10.2.20 Azenta Life Sciences